Janumet
Payments companies reported to CMS as associated with Janumet. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Janumet, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Janumet
These are the largest totals companies reported as associated with Janumet. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Luis Rivera Colon | Rio Piedras, PR | $351.66 | |
| Edgar Torres Garcia | Cidra, PR | Endocrinology, Diabetes & Metabolism | $250.98 |
| Martha Gomez | San Juan, PR | Endocrinology, Diabetes & Metabolism | $230.08 |
| Jamil Abou El Hossen Duarte | Fajardo, PR | Internal Medicine | $215.04 |
| Enrique Maldonado Corchado | Guaynabo, PR | Endocrinology, Diabetes & Metabolism | $179.31 |
| Carlos Vera Muniz | San Juan, PR | Family Medicine | $161.28 |
| Altagracia Alcantara Gonzalez | Bayamon, PR | Endocrinology, Diabetes & Metabolism | $160.00 |
| Sheila Mercado | Manati, PR | Endocrinology, Diabetes & Metabolism | $159.17 |
| Michelle Mangual Garcia | San Juan, PR | Endocrinology, Diabetes & Metabolism | $158.52 |
| Marylou Romo-Gritzewsky | Freedom, CA | Internal Medicine | $157.82 |
Prescribed Janumet?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.